- Home
- VERA vs SOC Comparison
VERA vs SOC Comparison
Compare VERA & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- SOC
- Stock Information
- Founded
- VERA 2016
- SOC 2020
- Country
- VERA United States
- SOC United States
- Employees
- VERA N/A
- SOC N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- SOC
- Sector
- VERA Health Care
- SOC
- Exchange
- VERA Nasdaq
- SOC Nasdaq
- Market Cap
- VERA 1.7B
- SOC 1.8B
- IPO Year
- VERA 2021
- SOC N/A
- Fundamental
- Price
- VERA $29.16
- SOC $13.35
- Analyst Decision
- VERA Buy
- SOC Buy
- Analyst Count
- VERA 9
- SOC 3
- Target Price
- VERA $62.25
- SOC $30.00
- AVG Volume (30 Days)
- VERA 1.2M
- SOC 5.9M
- Earning Date
- VERA 11-07-2025
- SOC 11-13-2025
- Dividend Yield
- VERA N/A
- SOC N/A
- EPS Growth
- VERA N/A
- SOC N/A
- EPS
- VERA N/A
- SOC N/A
- Revenue
- VERA N/A
- SOC N/A
- Revenue This Year
- VERA N/A
- SOC N/A
- Revenue Next Year
- VERA N/A
- SOC $208.30
- P/E Ratio
- VERA N/A
- SOC N/A
- Revenue Growth
- VERA N/A
- SOC N/A
- 52 Week Low
- VERA $18.53
- SOC $11.25
- 52 Week High
- VERA $51.61
- SOC $35.00
- Technical
- Relative Strength Index (RSI)
- VERA 53.54
- SOC 35.80
- Support Level
- VERA $29.50
- SOC $11.43
- Resistance Level
- VERA $32.17
- SOC $14.77
- Average True Range (ATR)
- VERA 1.34
- SOC 1.56
- MACD
- VERA -0.43
- SOC -0.14
- Stochastic Oscillator
- VERA 26.72
- SOC 23.76
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About SOC Sable Offshore Corp. Common Stock
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.